As­traZeneca ex­pands Cana­da R&D work, to add 500 jobs

As­traZeneca will ex­pand its Cana­da R&D foot­print, ex­pand­ing its cen­ter near Toron­to and cre­at­ing a new rare dis­eases re­search cen­ter there with its Alex­ion unit, the com­pa­ny said.

The UK drug­mak­er said the ex­pan­sion will add 500 jobs. The ex­ist­ing op­er­a­tions there help run many of As­traZeneca’s clin­i­cal tri­als, ac­cord­ing to the re­lease. Cur­rent­ly, As­traZeneca has about 1,200 em­ploy­ees in the coun­try, most­ly at its hub in the Toron­to sub­urbs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA